Byonyks Medical Devices

Byonyks Medical Devices is a medical device manufacturer focused on next-generation peritoneal dialysis systems for home-based kidney failure treatment. The company has received FDA 510(k) clearance for its X-1 Automated Peritoneal Dialysis (APD) Cycler, positioning it among a select group of manufacturers offering FDA-cleared APD devices. Byonyks' technology platform addresses a significant clinical need: the U.S. government's initiative to transition 80% of dialysis patients to home-based or transplant therapies, representing a major paradigm shift in a $120 billion industry that has relied on 40-year-old technology. The company's next-generation peritoneal dialysis systems are engineered to preserve peritoneal membrane integrity through biocompatible, toxin-free dialysate formulations, thereby extending patients' tenure on peritoneal dialysis therapy. Key product benefits include slower decline in residual kidney function (supported by the BALANZ clinical study), elimination of acid and pro-inflammatory mediators from dialysate, reduced malnutrition and atherosclerosis risk, and lower treatment costs through cost-effective consumables and high-performance device design. Byonyks serves the home dialysis market in the United States and internationally, targeting patients with chronic kidney disease seeking improved quality of life and clinical outcomes through home-based treatment modalities.